Sign In
Get Clay Free →

Suggestions

    Gorjan Hrustanovic

    Managing Director at BVF Partners L.P.

    Gorjan Hrustanovic, Ph.D., is a Managing Director at BVF Partners L.P., where he focuses on biotech and therapeutic investments.3 He was appointed to the Board of Directors at Nimbus Therapeutics in 2022.16

    Dr. Hrustanovic has a strong background in cancer biology and translational medicine. He obtained his Ph.D. in Cancer Biology and Cell Signaling from the University of California, San Francisco (UCSF), where his research focused on precision medicine and resistance to targeted therapies in lung cancer.23

    In addition to his role at Nimbus Therapeutics, Dr. Hrustanovic serves on the boards of several other biotech companies:

    • Rain Therapeutics, Inc.3
    • Olema Pharmaceuticals, Inc.34
    • Kymera Therapeutics, Inc.5

    He is also a board observer at 4D Molecular Therapeutics.23

    Prior to joining BVF Partners L.P. in 2015, Dr. Hrustanovic co-founded a small biotech-focused investment fund while at UCSF.3 His research has been published in peer-reviewed journals such as Nature Medicine, Cell Reports, and Oncogene.3

    Dr. Hrustanovic holds a BS degree in Molecular Biology and a BS in Economics and Management Science from the University of California, San Diego.23

    Related Questions

    What are Gorjan Hrustanovic's main responsibilities at Nimbus Therapeutics?
    How did Gorjan Hrustanovic's background in cancer biology influence his career in biotech?
    What other companies does Gorjan Hrustanovic serve on the board of?
    How has Gorjan Hrustanovic contributed to the success of BVF Partners, L.P?
    What are the key projects Gorjan Hrustanovic is involved in at Nimbus Therapeutics?
    Gorjan Hrustanovic
    Gorjan Hrustanovic, photo 1
    Gorjan Hrustanovic, photo 2
    Add to my network

    Location

    San Francisco, California, United States